News
Stocks drifted early Tuesday as investors look for more details on where tariffs stand for autos and tech products after ...
Asian shares have mostly gained, echoing a rally on Wall Street after President Donald Trump relaxed some of his tariffs and some stress from within the U.S. bond market seems to be easing.
10h
Investor's Business Daily on MSNStock Market Today: Dow Jones, S&P 500 Close Lower; But This Recent IPO Name Bolts Higher For 3rd Straight Day (Live Coverage)Stocks showed weakness Tuesday with the major indexes closing lower. But a recent IPO name climbed for a third straight day.
The Trump administration’s chaotic tariff rollout continues to spur volatility in the markets, but major U.S. stock indexes ...
China has ordered its airlines to ditch jet deliveries from Boeing following days of back-and-forth with President Trump over hikes in tariffs. The president’s 145 percent levy on Chinese goods drove ...
Caterpillar took center stage at the New York Stock Exchange on Tuesday where outgoing CEO Jim Umpleby rang the bell to open ...
Newsmax (NYSE: NMAX) stock is seeing another round of significant gains Tuesday. The company's share price was up 9.5% as of ...
We recently published a list of the 10 Best Oil Stocks to Invest in According to Billionaires. In this article, we are going ...
Shares of Rivian Automotive (NASDAQ:RIVN) were mostly flat during a.m. trading on Tuesday, falling by an unremarkable -0.29%, which did little to reverse the stock’s recent momentum that has resulted ...
Congressional Republicans are now three points below Congressional Democrats when it comes to trust in their economic policies from voters.
Meta CEO Mark Zuckerberg faced questions about his intentions in acquiring Instagram on the first day of a historic antitrust ...
In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia Cavazzoni, M.D., stepped down in January and joined Pfizer's C-suite as chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results